RedHill Biopharma
(NASDAQ) RDHL
RedHill Biopharma Financials at a Glance
Market Cap
$3.82M
Revenue (TTM)
$9.55M
Net Income (TTM)
$9.31M
EPS (TTM)
$0.00
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
1.27 (Average)
Dividend
$0.00
Beta (Volatility)
1.27 (Average)
Price
$0.74
Volume
51,295.92
Open
$0.79
Price
$0.74
Volume
51,295.92
Open
$0.79
Previous Close
$0.74
Daily Range
$0.71 - $0.79
52-Week Range
$0.71 - $3.31
Dividend
$0.00
Beta (Volatility)
1.27 (Average)
Price
$0.74
Volume
51,295.92
Open
$0.79
Previous Close
$0.74
Daily Range
$0.71 - $0.79
52-Week Range
$0.71 - $3.31
RDHL News
RDHL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout RedHill Biopharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
35
CEO
Dror Ben-Asher
Website
www.redhillbio.comHeadquarters
Tel Aviv, 6473921, IL
RDHL Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
-1%
Net Income Margin
-98%
Return on Equity
0%
Return on Capital
3%
Return on Assets
-51%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.82M
Shares Outstanding
5.09M
Volume
51.30K
Short Interest
0.00%
Avg. Volume
469.95K
Financials (TTM)
Gross Profit
$4.85M
Operating Income
$14.61M
EBITDA
$7.59M
Operating Cash Flow
$9.37M
Capital Expenditure
$9.00K
Free Cash Flow
$9.38M
Cash & ST Invst.
$4.62M
Total Debt
$356.00K
RedHill Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.04M
+58.6%
Gross Profit
$1.24M
+111.6%
Gross Margin
60.60%
N/A
Market Cap
$3.82M
N/A
Market Cap/Employee
$109.12K
N/A
Employees
35
N/A
Net Income
$2.07M
-33.8%
EBITDA
$2.10M
+47.6%
Quarterly Fundamentals
Net Cash
$2.65M
-60.5%
Accounts Receivable
$6.36M
+63.8%
Inventory
$3.17M
-16.7%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$214.00K
-41.8%
Return on Assets
-50.68%
N/A
Return on Invested Capital
2.70%
N/A
Free Cash Flow
$2.51M
+18.9%
Operating Cash Flow
$2.51M
+18.9%